Metabolic outcomes | Level compared | FEV1(L) β-coefficient (95% CI) | FVC (L) β-coefficient (95% CI) |
---|---|---|---|
Whole sample (n = 970) | |||
Fasting glycaemia (tertile) | 1 | 0 | 0 |
2 | 0.01 (-0.06 to 0.07) | 0.01 (-0.06 to 0.08) | |
3 | 0.04 (-0.02 to 0.11) | 0.03 (-0.04 to 0.10) | |
P value | 0.19 | 0.43 | |
HOMA-IR | Normal | 0 | 0 |
High | -0.08 (-0.13 to -0.03) | -0.11 (-0.17 to -0.05) | |
P value | 0.004 | <0.0001 | |
Metabolic syndrome | Not present | 0 | 0 |
Present | -0.13 (-0.21 to -0.05) | -0.18 (-0.27 to -0.09) | |
 | P value | 0.001 | <0.001 |
Men (n = 429) | |||
Fasting glycaemia (tertile) | 1 | 0 | 0 |
2 | -0.01 (-0.12 to 0.09) | -0.001 (-0.13 to 0.12) | |
3 | -0.06 (-0.16 to 0.04) | -0.06 (-0.18 to 0.05) | |
P value | 0.24 | 0.25 | |
HOMA-IR | Normal | 0 | 0 |
High | -0.12 (-0.21 to -0.03) | -0.13 (-0.23 to -0.03) | |
P value | 0.007 | 0.01 | |
Metabolic syndrome | Not present | 0 | 0 |
Present | -0.18 (-0.32 to -0.05) | -0.20 (-0.35 to -0.04) | |
 | P value | 0.009 | 0.01 |
Women (n = 521) | |||
Fasting glycaemia (tertile) | 1 | 0 | 0 |
2 | -0.002 (-0.06 to 0.06) | -0.03 (-0.07 to 0.06) | |
3 | 0.01 (-0.06 to 0.08) | -0.03 (-0.11 to 0.04) | |
P value | 0.80 | 0.41 | |
HOMA-IR | Normal | 0 | 0 |
High | -0.03 (-0.09 to 0.04) | -0.07 (-0.14 to -0.004) | |
P value | 0.43 | 0.04 | |
Metabolic syndrome | Not present | 0 | 0 |
Present | -0.09 (-0.18 to 0.01) | -0.16 (-0.26 to -0.05) | |
 | P value | 0.08 | 0.003 |